PTRH1 and pancreatic neoplasm: We established a diabetes model in C57 mice and implanted an orthotopic pancreatic tumor when the mice blood glucose reached the standard of diabetes (> 11.1 mmol/l) to describe the different immune landscapes of the pancreatic TME with different blood levels and PTRH1 expression (Fig. 6B, C).